Ian Townsend
Gründer bei Townsend Family Investments LLP
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Deborah A. O’Neil | M | 53 |
NovaBiotics Ltd.
NovaBiotics Ltd. Pharmaceuticals: MajorHealth Technology NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom. | 20 Jahre |
Bryan Harvey Bodek | M | 71 |
The Medical House Ltd.
The Medical House Ltd. Electronic Equipment/InstrumentsElectronic Technology The Medical House Ltd. manufactures and develops surgical instrumentation and drug delivery products. The company operates two divisions Orthopedic and Drug Delivery Systems. The Orthopedic division designs, develops and manufactures instruments and devices for use in orthopedic surgery. The Drug Delivery Systems divisions manufactures and supplies the mhi-500 needle-free insulin delivery system. The company was founded by Ian Townsend in1988 and is headquartered in Sheffield, the United Kingdom.
NovaBiotics Ltd.
NovaBiotics Ltd. Pharmaceuticals: MajorHealth Technology NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom. | 15 Jahre |
Georgina Anne Townsend | F | 67 |
Reset Certification Scheme Ltd.
Reset Certification Scheme Ltd. Information Technology ServicesTechnology Services Reset Certification Scheme Ltd. offers safety-enhancing, time and cost-saving products and tools for any organization that needs to bring third-party contractors onto their site. The company was founded by Gary Duce and is headquartered in Sheffield, the United Kingdom.
Townsend Investments Ltd.
Townsend Investments Ltd. Investment ManagersFinance Townsend Investments Ltd (Townsend Investments) is venture capital firm is founded in 2013 by Ian Townsend. The firm is headquartered in Harrogate, UK. | - |
Gary Duce | M | - |
Reset Certification Scheme Ltd.
Reset Certification Scheme Ltd. Information Technology ServicesTechnology Services Reset Certification Scheme Ltd. offers safety-enhancing, time and cost-saving products and tools for any organization that needs to bring third-party contractors onto their site. The company was founded by Gary Duce and is headquartered in Sheffield, the United Kingdom. | - |
Arthur Duce | M | - |
Reset Certification Scheme Ltd.
Reset Certification Scheme Ltd. Information Technology ServicesTechnology Services Reset Certification Scheme Ltd. offers safety-enhancing, time and cost-saving products and tools for any organization that needs to bring third-party contractors onto their site. The company was founded by Gary Duce and is headquartered in Sheffield, the United Kingdom. | - |
Paul Grant Ellis | M | 67 |
NovaBiotics Ltd.
NovaBiotics Ltd. Pharmaceuticals: MajorHealth Technology NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom. | 11 Jahre |
Margaret Scott | F | 63 |
The Medical House Ltd.
The Medical House Ltd. Electronic Equipment/InstrumentsElectronic Technology The Medical House Ltd. manufactures and develops surgical instrumentation and drug delivery products. The company operates two divisions Orthopedic and Drug Delivery Systems. The Orthopedic division designs, develops and manufactures instruments and devices for use in orthopedic surgery. The Drug Delivery Systems divisions manufactures and supplies the mhi-500 needle-free insulin delivery system. The company was founded by Ian Townsend in1988 and is headquartered in Sheffield, the United Kingdom. | 16 Jahre |
Peter Townsend | M | - |
Townsend Investments Ltd.
Townsend Investments Ltd. Investment ManagersFinance Townsend Investments Ltd (Townsend Investments) is venture capital firm is founded in 2013 by Ian Townsend. The firm is headquartered in Harrogate, UK. | - |
Stephen Mann | M | - |
Reset Certification Scheme Ltd.
Reset Certification Scheme Ltd. Information Technology ServicesTechnology Services Reset Certification Scheme Ltd. offers safety-enhancing, time and cost-saving products and tools for any organization that needs to bring third-party contractors onto their site. The company was founded by Gary Duce and is headquartered in Sheffield, the United Kingdom. | - |
Malcolm Barratt-Johnson | M | 61 |
NovaBiotics Ltd.
NovaBiotics Ltd. Pharmaceuticals: MajorHealth Technology NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom. | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
David Urquhart | M | 64 |
The Medical House Ltd.
The Medical House Ltd. Electronic Equipment/InstrumentsElectronic Technology The Medical House Ltd. manufactures and develops surgical instrumentation and drug delivery products. The company operates two divisions Orthopedic and Drug Delivery Systems. The Orthopedic division designs, develops and manufactures instruments and devices for use in orthopedic surgery. The Drug Delivery Systems divisions manufactures and supplies the mhi-500 needle-free insulin delivery system. The company was founded by Ian Townsend in1988 and is headquartered in Sheffield, the United Kingdom. | 7 Jahre |
Stephen Shaw | M | 64 |
The Medical House Ltd.
The Medical House Ltd. Electronic Equipment/InstrumentsElectronic Technology The Medical House Ltd. manufactures and develops surgical instrumentation and drug delivery products. The company operates two divisions Orthopedic and Drug Delivery Systems. The Orthopedic division designs, develops and manufactures instruments and devices for use in orthopedic surgery. The Drug Delivery Systems divisions manufactures and supplies the mhi-500 needle-free insulin delivery system. The company was founded by Ian Townsend in1988 and is headquartered in Sheffield, the United Kingdom. | - |
Andrew Justin Radcliffe Porter | M | - |
NovaBiotics Ltd.
NovaBiotics Ltd. Pharmaceuticals: MajorHealth Technology NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom. | 12 Jahre |
John Kingston Pool | M | 80 |
The Medical House Ltd.
The Medical House Ltd. Electronic Equipment/InstrumentsElectronic Technology The Medical House Ltd. manufactures and develops surgical instrumentation and drug delivery products. The company operates two divisions Orthopedic and Drug Delivery Systems. The Orthopedic division designs, develops and manufactures instruments and devices for use in orthopedic surgery. The Drug Delivery Systems divisions manufactures and supplies the mhi-500 needle-free insulin delivery system. The company was founded by Ian Townsend in1988 and is headquartered in Sheffield, the United Kingdom. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigtes Königreich | 14 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ian Townsend
- Persönliches Netzwerk